Jpmorgan Healthcare Leaders ETF Rating → Shocking $16T Elon Musk Crypto Leak (From Crypto 101 Media) (Ad) Free JDOC Stock Alerts $58.56 -0.04 (-0.07%) (As of 06/7/2024 ET) Add Compare Share Share RatingsStock AnalysisChartHoldingsRatingsStock AnalysisChartHoldingsRatings Jpmorgan Healthcare Leaders ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.JDOC Aggregate RatingModerate Buy2.77Holdings in JDOC have an aggregate rating of Moderate Buy based on 548 analyst ratings issued in the past year covering 38 companies (72.2% of the portfolio).JDOC Aggregate Price Target$63.939.16% UpsideHigh Prediction$77.18Average Prediction$63.93Low Prediction$49.78Holdings in JDOC have an aggregate price target of $63.93 and a range of $49.78 to $77.18 covering 38 companies (72.2% of the portfolio).JDOC Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy4 Buy rating(s)Moderate Buy29 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Jpmorgan Healthcare Leaders ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 38 JDOC Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings9.26%LLYEli Lilly and Company$849.99+1.5%4 of 5 stars2.84$787.53 -7.3%19Analyst ForecastInsider Selling7.98%UNHUnitedHealth Group$490.69-2.2%5 of 5 stars2.95$578.75 17.9%20Dividend IncreaseAnalyst UpgradeNews Coverage4.73%REGNRegeneron Pharmaceuticals$1,002.95+0.2%4 of 5 stars2.76$989.86 -1.3%21Analyst ForecastInsider SellingNews Coverage4.45%ABBVAbbVie$169.42+0.5%5 of 5 stars2.86$178.21 5.2%14Analyst Upgrade3.53%DHRDanaher$263.08-1.8%4 of 5 stars2.67$269.29 2.4%15Positive News2.87%JNJJohnson & Johnson$147.08+0.5%5 of 5 stars2.38$174.07 18.4%13Analyst Forecast2.69%CIThe Cigna Group$338.10+0.1%5 of 5 stars3.00$373.87 10.6%16Ex-Dividend2.68%SYKStryker$349.33-0.1%5 of 5 stars2.79$370.58 6.1%19Positive News2.60%BSXBoston Scientific$77.11+1.3%5 of 5 stars2.95$76.70 -0.5%22Analyst UpgradeOptions VolumePositive News2.27%HCAHCA Healthcare$337.44+0.2%5 of 5 stars2.83$325.59 -3.5%18Analyst UpgradePositive News2.12%TMOThermo Fisher Scientific$581.09+0.2%5 of 5 stars2.72$607.94 4.6%18Insider Selling2.06%MRKMerck & Co., Inc.$130.67+0.1%4 of 5 stars2.69$133.00 1.8%13Analyst Forecast2.04%BDXBecton, Dickinson and Company$240.63+0.2%5 of 5 stars2.83$280.17 16.4%6Analyst Upgrade1.89%MCKMcKesson$586.90+0.1%4 of 5 stars2.87$571.47 -2.6%15Analyst DowngradeInsider Selling1.86%EWEdwards Lifesciences$88.14+0.5%5 of 5 stars2.65$95.06 7.8%20Analyst RevisionPositive News1.63%BMYBristol-Myers Squibb$41.48+1.5%5 of 5 stars2.11$60.00 44.6%191.56%AMGNAmgen$305.02-0.2%5 of 5 stars2.52$305.65 0.2%21Analyst RevisionPositive News1.34%ISRGIntuitive Surgical$417.61-0.1%4 of 5 stars2.78$403.67 -3.3%18Insider Selling1.29%IQVIQVIA$219.23-0.6%4 of 5 stars2.81$258.40 17.9%16Analyst ForecastPositive News1.09%NTRANatera$111.19+1.8%2 of 5 stars3.00$101.19 -9.0%160.96%SWAVShockwave Medical$334.750.0%4 of 5 stars2.09$309.11 -7.7%11Positive NewsHigh Trading Volume0.84%DXCMDexCom$115.79+0.4%5 of 5 stars2.87$140.94 21.7%15Positive News0.83%ABTAbbott Laboratories$107.58+3.2%5 of 5 stars2.70$120.64 12.1%10Analyst ForecastPositive News0.82%EXASExact Sciences$42.93-3.9%4 of 5 stars2.92$93.07 116.8%13Analyst Revision0.77%TWSTTwist Bioscience$50.46-4.8%3 of 5 stars3.00$44.00 -12.8%7Analyst ForecastNews CoverageGap Down0.76%WSTWest Pharmaceutical Services$314.68-0.2%5 of 5 stars2.80$435.20 38.3%5Positive News0.74%ALGNAlign Technology$255.54-0.7%5 of 5 stars2.44$353.00 38.1%9Analyst ForecastPositive News0.73%ACHCAcadia Healthcare$69.42-3.3%5 of 5 stars2.67$87.56 26.1%9Analyst Revision0.68%BPMCBlueprint Medicines$103.34-1.0%1 of 5 stars2.63$108.00 4.5%16Analyst ForecastInsider SellingNews Coverage0.68%EVHEvolent Health$23.48+0.6%2 of 5 stars2.92$42.00 78.9%12Positive News0.66%CNCCentene$69.81-0.9%5 of 5 stars2.43$84.93 21.7%14Positive News0.65%NBIXNeurocrine Biosciences$134.97+1.4%5 of 5 stars2.80$150.85 11.8%25Positive News0.58%HALOHalozyme Therapeutics$50.85-1.1%5 of 5 stars2.75$54.13 6.4%8Analyst ForecastAnalyst RevisionNews Coverage0.57%ITCIIntra-Cellular Therapies$68.41-0.2%5 of 5 stars2.90$92.73 35.5%10News CoveragePositive News0.52%INSPInspire Medical Systems$157.79+0.9%5 of 5 stars2.69$253.87 60.9%16Positive News0.51%RVMDRevolution Medicines$40.34+0.5%3 of 5 stars3.10$43.20 7.1%100.50%AGIOAgios Pharmaceuticals$47.61-0.4%2 of 5 stars2.50$45.33 -4.8%4Analyst ForecastAnalyst RevisionNews Coverage0.49%SRPTSarepta Therapeutics$123.32+5.0%5 of 5 stars2.80$164.00 33.0%15 This page (NYSEARCA:JDOC) was last updated on 6/9/2024 by MarketBeat.com Staff From Our PartnersCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredExposed: 3 CENT Crypto to Explode June 24th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredRSVP: Charles Payne’s Cash Flow WorkshopDid you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...Unstoppable Prosperity | Sponsored"The Biggest Drug Ever" Is ComingUBS bank predicts it will become "The Biggest Drug Ever." The Wall Street Journal believes it will be "Phar...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Jpmorgan Healthcare Leaders ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Jpmorgan Healthcare Leaders ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
